Clinical Trials Directory

Trials / Unknown

UnknownNCT04579562

Regional COVID Epidemiology in England (RECEDE)

Regional Epidemiology of COVID-19 and Acute Kidney Injury in England

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

The COVID-19 pandemic has exposed the unwanted variation in outcomes as evidence by Public Health England's report on increased mortality in regions of the country. For example, UHDB, in East Midlands, has reported a high crude mortality as compared to other Trusts in the region.8 There may also have been variation in the incidence of complications of COVID-19 in the form of AKI, which may have influenced mortality. Variation in outcomes may be because of various factors - differing population demographics, underlying health conditions in the population, deprivation, physician preference and knowledge and ethnic diversity. Unwanted variation is care that is not consistent with a patient's preference or related to \[their\] underlying illness. It is important to understand the reason for unwanted variation in outcomes associated with COVID-19 to minimise patient harm and reduce morbidity and mortality.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThis is observational, non-interventional study

Timeline

Start date
2020-11-01
Primary completion
2021-03-31
Completion
2021-10-31
First posted
2020-10-08
Last updated
2020-10-08

Source: ClinicalTrials.gov record NCT04579562. Inclusion in this directory is not an endorsement.